Amarnath Singh, PhD

Affiliate Member

Research Program:

Cancer Prevention and Population Sciences

Faculty Rank:

Postdoctoral Research Fellow

Campus:

University of Arkansas for Medical Sciences

College:

College of Public Health

Department:

College of Public health

Cancer Research Interest

Disease Site Focus: Breast, Prostate, Thoracic/ Lung
Research Focus Area: Carcinogenesis, Health Disparities, Diagnosis/ Prognosis, Informatics, Prevention
Type of Research: Population Sciences, Clinical, Translational
Research Keywords: Metabolomics, Epigenetics, Multiomics, Transcriptomics, Lipidomics, Public health, Exposome
Research Interest Statement: Research Statement My research focuses on how environmental exposures and modifiable behaviors shape cancer risk, treatment toxicity, and survivorship through molecular changes. I use epigenomics, metabolomics/lipidomics, and exposure biomarkers to identify minimally invasive markers of risk, prognosis, and adverse treatment outcomes. My work examines how toxicants such as tobacco-related compounds, VOCs, PAHs, and arsenic contribute to carcinogenesis through pathways including immune dysregulation, oxidative stress, and accelerated biological aging. Overall, my goal is to advance equitable, multi-omics strategies for precision prevention and survivorship to improve cancer outcomes and reduce health disparities.

Singh A, Bakhtyar M, Jun SR, [et al.]. A narrative review of metabolomics approaches in identifying biomarkers of doxorubicin-induced cardiotoxicity. Metabolomics : Official journal of the Metabolomic Society. 2025 21(3):68. PMID: 40381141. PMCID: PMC12085340.
Kumari K, Kumar V, Verma C, [et al., including Singh A]. DNA Methylation in Lung Cancer: Predictive Biomarkers for Effective Immunotherapy. International journal of general medicine. 2025 18:7893-7910. PMID: 41497171.
Ghaemi B, Tanwar S, Singh A, [et al.]. Cell-Penetrating and Enzyme-Responsive Peptides for Targeted Cancer Therapy: Role of Arginine Residue Length on Cell Penetration and In Vivo Systemic Toxicity. ACS applied materials & interfaces. 2024 16(9):11159-11171. PMID: 38385360.
Singh A, Kinnebrew G, Hsu PC, [et al.]. Untargeted Metabolomics and Body Mass in Adolescents: A Cross-Sectional and Longitudinal Analysis. Metabolites. 2023 13(8). PMID: 37623843. PMCID: PMC10456720.
Singh AP, Jeffus SK, Shalin SC. Cervical dysplasia in a patient with inherited epidermodysplasia verruciformis-A mere coincidence?. Journal of cutaneous pathology. 2021 48(6):763-770. PMID: 33319409.